Depressive symptoms linked to early death in cancer survivors

NewsGuard 100/100 Score

Depressed cancer survivors are twice as likely to die prematurely than those who do not suffer from depression, irrespective of the cancer site. That's according to a new study, by Floortje Mols and colleagues, from Tilburg University in The Netherlands. Their work is published online in Springer's Journal of Cancer Survivorship.

The prevalence of cancer is rising, as are the number of individuals who are cured of their cancer or are living with it as a chronic disease. This is partly due to the aging of the population and more effective treatments. As a result, many of these survivors face continuing problems due to cancer and its treatment, including a high prevalence of depression.

Mols and team examined whether depressive symptoms observed between one and ten years after cancer diagnosis were linked to an increased risk of premature death two to three years later. Their work focused on survivors of endometrial cancer, colorectal cancer, lymphoma or multiple myeloma, where little work looking at this potential link has been done to date.

They analyzed data collected from several large population-based surveys in 2008 and 2009. A total of 3,080 cancer survivors completed questionnaires to identify symptoms of depression.

The authors found that depressive symptoms increased the risk of death: clinically high levels of depressive symptoms were more common in those who died than in those who survived. Overall, after controlling for treatment, type of cancer, co-morbidity, and metastasis, one-to-ten-year cancer survivors with depression were twice as likely to have died early.

The researchers conclude: "Paying attention to the recognition and treatment of depressive symptoms in this patient group is key. The next step is to investigate the possible mechanisms that might explain the association between depressive symptoms and death from cancer. We also need to better understand whether treatments for depressive symptoms in cancer patients have life-prolonging effects."

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Aspirin's immune-boosting effects in colorectal cancer revealed